Transcatheter mitral valve-in-valve replacement with an Edwards Lifesciences Sapien 3 valve was associated with positive one-year outcomes in a cohort of 50 intermediate-risk patients. Researchers plan to track the group for 10 years total.
About us
Cardiovascular Business is a news, business and technology source for cardiovascular medicine. We focus on the business and economics behind the foremost clinical, interventional, surgical and information technologies as well as pharmaceuticals and related products that are key to achieving a successful integrated cardiovascular practice.
- Website
-
http://www.cardiovascularbusiness.com/
External link for Cardiovascular Business
- Industry
- Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Providence, RI
- Type
- Privately Held
- Founded
- 2007
Locations
-
Primary
Promenade Street
Providence, RI, US
Employees at Cardiovascular Business
Updates
-
Getting pharmacists more involved in patient care could make a significant impact.
Pharmacists help lower stroke risk in patients with undiagnosed, undertreated AFib
cardiovascularbusiness.com
-
According to FibriCheck this key approval of its advanced algorithms and smartphone application is “just the beginning.”
FDA clears heart rhythm AI that turns smartphones into medical devices
cardiovascularbusiness.com
-
Video - Sahil Parikh, MD, New York-Presbyterian, explains key findings of the REAL-PE study comparing mechanical thrombectomy to ultrasound assisted catheter thrombolysis. #pulmonaryembolism Sahil Parikh #VTE #PERT #cardiology
REAL-PE highlights disparities in pulmonary embolism care
cardiovascularbusiness.com
-
Major complications are rare during percutaneous coronary intervention. When they do happen, however, the in-hospital mortality rate is approximately 20%.
‘Failure to rescue’ after PCI: 1 in 5 patients die when complications occur
cardiovascularbusiness.com
-
Researchers tracked SWEDEHEART data from more than 8,000 #TAVR patients treated from 2008 to 2022. Overall, they said, PPM after TAVR was rare, and its impact on outcomes was "negligible."
Prosthesis-patient mismatch after TAVR makes minimal impact on long-term outcomes
cardiovascularbusiness.com
-
Under this new arrangement, advanced AI software from Volta Medical will be integrated into GE HealthCare offerings.
Volta Medical, GE Healthcare partner on AI-powered AFib treatments
cardiovascularbusiness.com
-
Some of the most talked about data at ACC.24 were the results of a late-breaking clinical trial comparing different transcatheter aortic valve replacement (TAVR) valves in patients with a small aortic annulus. Eighty-seven percent of patients were women, a statistic practically unheard of in TAVR research. Medtronic
Q&A: Interventional cardiologist breaks down SMART data and TAVR valve performance in patients with small annuli
cardiovascularbusiness.com
-
While 16% of male cardiologists have a net worth of more than $5 million, the same is true for just 6% of female cardiologists. That's one of the many key takeaways from a new report on cardiologist compensation, wealth and debt.
Wealthiest cardiologists tend to be men—least wealthy tend to be women
cardiovascularbusiness.com
-
Magenta Medical Ltd. plans to use some of the new financing to help secure FDA approval for its Elevate LVAD. Novo Holdings the controlling shareholder of Novo Nordisk, led the funding round.
Medical device company raises another $105M for new-look heart pump
cardiovascularbusiness.com